Cost‐effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore

BACKGROUND: CDK4/6 inhibitors have shown promising results for treating advanced breast cancer (ABC) and are routinely used in Singapore. In view of their high costs, it is important to assess their relative value compared to existing standards of care in the local setting. AIMS: This study evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Loke, Lydia, Lee, Soo‐Chin, Pearce, Fiona, Ng, Kwong, Aziz, Mohamed Ismail Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941436/
https://www.ncbi.nlm.nih.gov/pubmed/33085843
http://dx.doi.org/10.1002/cnr2.1308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941436/
https://www.ncbi.nlm.nih.gov/pubmed/33085843
http://dx.doi.org/10.1002/cnr2.1308

Ejemplares similares